Unknown NA INTERVENTIONAL 2-arm NCT01695447

Duct-to-mucosa Versus Invagination for Pancreaticojejunostomy

Randomised Controlled Trail of Duct-to-mucosa Versus Invagination for Pancreaticojejunostomy After Pancreaticoduodenectomy

Sponsor: TingBo Liang

Conditions Biliary Tract Neoplasms Pancreatic Neoplasms

Interventions Internal stent duct-to-mucosa invagination

Updated 7 times since 2017 Last updated: Jan 25, 2017 Started: Jan 31, 2012 Primary completion: Dec 31, 2017 Completion: Dec 31, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Biliary Tract Neoplasms and Pancreatic Neoplasms and is currently ongoing. TingBo Liang leads this study, which shows 7 recorded versions since 2012 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Feb 2019 — Jan 2021 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
Jun 2018 — Feb 2019 [monthly]

Recruiting NA

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Recruiting NA

Status: Unknown Status → Recruiting
Jan 2017 — Feb 2017 [monthly]

Unknown Status NA

First recorded

Jan 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

TingBo Liang

Data source: Zhejiang University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Hangzhou, China